FDA Inspection 662123 — Cosette Pharmaceuticals, Inc.

Cosette Pharmaceuticals, Inc. — FEI 2210277

The FDA completed an inspection of Cosette Pharmaceuticals, Inc. on May 17, 2010 in South Plainfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 17, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
South Plainfield, NJ (United States)

Citations

IDCFRDescription
103321 CFR 211.22(a)Authority lacking to review records, investigate errors
104921 CFR 211.22(a)Approve or reject components, products
117721 CFR 211.63Equipment Design, Size and Location
121521 CFR 211.67(b)Written procedures not established/followed
202821 CFR 211.192Extent of discrepancy, failure investigations
430521 CFR 211.68(b)Backup data not assured as exact and complete
438921 CFR 211.198(a)Procedures to be written and followed
457621 CFR 211.192No written record of investigation